Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise.

Hamilton DL, Philp A, MacKenzie MG, Baar K.

PLoS One. 2010 Jul 16;5(7):e11624. doi: 10.1371/journal.pone.0011624.

2.

Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.

McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Dorfman AL, Longnus S, Pende M, Martin KA, Blenis J, Thomas G, Izumo S.

Mol Cell Biol. 2004 Jul;24(14):6231-40.

3.

Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling.

Miyazaki M, McCarthy JJ, Fedele MJ, Esser KA.

J Physiol. 2011 Apr 1;589(Pt 7):1831-46. doi: 10.1113/jphysiol.2011.205658. Epub 2011 Feb 7.

4.

The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.

Kalista S, Schakman O, Gilson H, Lause P, Demeulder B, Bertrand L, Pende M, Thissen JP.

Endocrinology. 2012 Jan;153(1):241-53. doi: 10.1210/en.2011-1687. Epub 2011 Nov 15.

PMID:
22087027
5.

A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy.

Spangenburg EE, Le Roith D, Ward CW, Bodine SC.

J Physiol. 2008 Jan 1;586(1):283-91. Epub 2007 Nov 1.

6.

Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.

Ching JK, Luebbert SH, Collins RL 4th, Zhang Z, Marupudi N, Banerjee S, Hurd RD, Ralston L, Fisher JS.

Exp Physiol. 2013 Feb;98(2):526-35. doi: 10.1113/expphysiol.2012.066357. Epub 2012 Aug 31.

7.

Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers.

Koopman R, Zorenc AH, Gransier RJ, Cameron-Smith D, van Loon LJ.

Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1245-52. Epub 2006 Jan 24.

8.

Exercise improves skeletal muscle insulin resistance without reduced basal mTOR/S6K1 signaling in rats fed a high-fat diet.

Liao B, Xu Y.

Eur J Appl Physiol. 2011 Nov;111(11):2743-52. doi: 10.1007/s00421-011-1892-5. Epub 2011 Mar 15.

PMID:
21404070
9.

Serum IGF-I-deficiency does not prevent compensatory skeletal muscle hypertrophy in resistance exercise.

Matheny RW, Merritt E, Zannikos SV, Farrar RP, Adamo ML.

Exp Biol Med (Maywood). 2009 Feb;234(2):164-70. doi: 10.3181/0808-RM-251. Epub 2008 Dec 8. Erratum in: Exp Biol Med (Maywood). 2009 Oct;234(10):1. Matheny, Wayne [corrected to Matheny, Ronald W].

PMID:
19064939
10.

Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.

Joassard OR, Amirouche A, Gallot YS, Desgeorges MM, Castells J, Durieux AC, Berthon P, Freyssenet DG.

Int J Biochem Cell Biol. 2013 Nov;45(11):2444-55. doi: 10.1016/j.biocel.2013.07.019. Epub 2013 Aug 2.

PMID:
23916784
11.

Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice.

Shefi-Friedman L, Wertheimer E, Shen S, Bak A, Accili D, Sampson SR.

Am J Physiol Endocrinol Metab. 2001 Jul;281(1):E16-24.

12.

Insulin-like growth factor-1 and PTEN deletion enhance cardiac L-type Ca2+ currents via increased PI3Kalpha/PKB signaling.

Sun H, Kerfant BG, Zhao D, Trivieri MG, Oudit GY, Penninger JM, Backx PH.

Circ Res. 2006 Jun 9;98(11):1390-7. Epub 2006 Apr 20.

13.
14.

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ.

Nat Cell Biol. 2001 Nov;3(11):1009-13.

PMID:
11715022
15.

[Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].

Liao DW, Wang L, Zhang XG, Liu MQ.

Ai Zheng. 2006 Oct;25(10):1238-42. Chinese.

PMID:
17059767
17.

Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy.

Philippou A, Halapas A, Maridaki M, Koutsilieris M.

J Musculoskelet Neuronal Interact. 2007 Jul-Sep;7(3):208-18. Review.

18.
19.

PTEN expression contributes to the regulation of muscle protein degradation in diabetes.

Hu Z, Lee IH, Wang X, Sheng H, Zhang L, Du J, Mitch WE.

Diabetes. 2007 Oct;56(10):2449-56. Epub 2007 Jul 10.

20.

S6k1 is not required for Pten-deficient neuronal hypertrophy.

Chalhoub N, Kozma SC, Baker SJ.

Brain Res. 2006 Jul 19;1100(1):32-41. Epub 2006 Jun 13.

PMID:
16777079

Supplemental Content

Support Center